Rogério Silva Rosada

Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Abstract
The increasing numbers of tuberculosis infected people, the rising of Mycobacterium tuberculosis multi-drug resistant (MDR) strain and further the extensively-drug resistant strain (XDR), pursued to new challenges on scientific community regarding of prophylactic and therapeutic tools for tuberculosis (TB) control. To develop new strategies to combat TB is necessary to understand the role…
Identification of innate immune response factors on liver associated to protection against Mycobacterium tuberculosis infection, BP.PD
Abstract
DNA vaccines have been extensively studied since 1992 as a new strategy to control infection diseases. Although these vaccines have been shown highly efficient in several experimental models and, in some situations, in humans clinical trials they require high amounts of DNA to induce protective immune response. In this way, the development of approachs that use lower amounts of plasmid DN…
Evaluation of a new DNA-Hsp65 vaccine construct with a nuclear localizing sequence carried by hyaluronic acid liposomes and delivery by intranasal route, in the prophylaxis and therapy of experimental tuberculosis, BP.DR

Source:Lattes Curriculum

CV Lattes ResearcherID

3 / 2	Completed scholarships in Brazil

Associated processes

Short URL

Compartilhe esta página

Abstract

Abstract